Area of research
Epidemiology · Immunology
Research interest
Research interests include Cervical Cancer and HPV Research, Immunotherapy and Immune Responses, Hepatitis B Virus Studies, and vaccines and immunoinformatics approaches.
Assessment of Mycobacterium tuberculosis dodecin scaffold as a multimerization platform on the immunogenicity of HPV L2 antigens
Scientific approaches to defining <scp>HPV</scp> vaccine‐induced protective immunity
Scientific approaches toward improving cervical cancer elimination strategies
A safe and potentiated multi-type HPV L2-E7 nanoparticle vaccine with combined prophylactic and therapeutic activity
Inter-epitope spacer variation within polytopic L2-based human papillomavirus antigens affects immunogenicity
Lack of detectable HPV18 antibodies in 14% of quadrivalent vaccinees in a longitudinal cohort study
An update on one-dose HPV vaccine studies, immunobridging and humoral immune responses – A meeting report
Advances on two serological assays for human papillomavirus provide insights on the reactivity of antibodies against a cross-neutralization epitope of the minor capsid protein L2
Next generation L2-based HPV vaccines cross-protect against cutaneous papillomavirus infection and tumor development
A broadly protective vaccine against cutaneous human papillomaviruses
Enhanced immunogenicity of a positively supercharged archaeon thioredoxin scaffold as a cell-penetrating antigen carrier for peptide vaccines
Sustainability of neutralising antibodies induced by bivalent or quadrivalent HPV vaccines and correlation with efficacy: a combined follow-up analysis of data from two randomised, double-blind, multicentre, phase 3 trials
Inducible expression of human papillomavirus‐16 L1 capsomeres in the plastomes of <i>Nicotiana tabacum</i>: Transplastomic plants develop normal flowers and pollen
Peak neutralizing and cross-neutralizing antibody levels to human papillomavirus types 6/16/18/31/33/45/52/58 induced by bivalent and quadrivalent HPV vaccines
Broad Neutralization Responses Against Oncogenic Human Papillomaviruses Induced by a Minor Capsid L2 Polytope Genetically Incorporated Into Bacterial Ferritin Nanoparticles
Combined prophylactic and therapeutic immune responses against human papillomaviruses induced by a thioredoxin-based L2-E7 nanoparticle vaccine
Minor Capsid Protein L2 Polytope Induces Broad Protection against Oncogenic and Mucosal Human Papillomaviruses